跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Meropenem Labatec IV Powder for Injection or Infusion 500mg/vial - HSA Drug Approval Details
Approvals
/
HSA
/
Meropenem Labatec IV Powder for Injection or Infusion 500mg/vial
Approved
STANDARD
Meropenem Labatec IV Powder for Injection or Infusion 500mg/vial
Unknown
🇸🇬 Health Sciences Authority
Approval Date
Jan 13, 2026
Approval ID
d62d2755e4c73411
Company
Unknown
Type
Standard
Approval Details
Approval Id
d62d2755e4c73411
Drug Name
Meropenem Labatec IV Powder for Injection or Infusion 500mg/vial
Active Ingredients
Meropenem Trihydrate 570 mg eqv to Meropenem anhydrous
500mg
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jan 13, 2026
Approval ID
d62d2755e4c73411
Type
Standard
Back to HSA Approvals
